Baxter To Exit Drug Price Inflation MDL For $30M

Law360, New York (October 07, 2011, 4:49 PM ET) -- Baxter Healthcare Corp. on Friday reached a $29.8 million settlement in Massachusetts with the relator in multidistrict litigation accusing pharmaceutical companies of reporting inflated average wholesale prices of drugs to Medicaid programs.

Both Baxter and the relator told U.S. District Judge Patti B. Saris, who is overseeing the MDL, that they wished to settle their dispute “to avoid the delay, expense, inconvenience and uncertainty of protracted litigation of these disputed claims.”

Under the terms of the settlement agreement, the U.S. will get $25 million, while $1.6...
To view the full article, register now.